Rockefeller Capital Management L.P. Increases Holdings in Corteva, Inc. $CTVA

Rockefeller Capital Management L.P. lifted its stake in shares of Corteva, Inc. (NYSE:CTVA) by 40.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 77,349 shares of the company’s stock after purchasing an additional 22,437 shares during the quarter. Rockefeller Capital Management L.P.’s holdings in Corteva were worth $5,185,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in CTVA. JPL Wealth Management LLC purchased a new position in Corteva during the 3rd quarter valued at about $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in shares of Corteva in the fourth quarter worth about $27,000. Bank of Jackson Hole Trust purchased a new stake in shares of Corteva in the fourth quarter worth about $28,000. Cornerstone Financial Management LLC bought a new position in shares of Corteva in the fourth quarter valued at approximately $29,000. Finally, Basepoint Wealth LLC purchased a new position in Corteva during the fourth quarter valued at approximately $30,000. Institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 1.2%

Shares of Corteva stock opened at $82.60 on Friday. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a 1 year low of $60.53 and a 1 year high of $85.63. The firm has a market cap of $55.24 billion, a PE ratio of 48.59, a PEG ratio of 2.50 and a beta of 0.57. The company has a 50 day simple moving average of $79.38 and a two-hundred day simple moving average of $76.20.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. The firm had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business’s revenue for the quarter was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. Analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Monday, June 1st. Corteva’s dividend payout ratio is currently 42.35%.

Analysts Set New Price Targets

CTVA has been the topic of a number of analyst reports. BNP Paribas Exane upped their target price on shares of Corteva from $74.00 to $77.00 in a report on Wednesday, May 6th. Mizuho raised their price target on shares of Corteva from $82.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, April 15th. Berenberg Bank upped their price target on shares of Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Argus increased their price objective on Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research report on Tuesday, March 31st. Finally, Deutsche Bank Aktiengesellschaft lifted their price objective on Corteva from $90.00 to $100.00 in a research note on Monday, May 11th. Fourteen research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, Corteva has a consensus rating of “Moderate Buy” and an average price target of $88.81.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.